New patent for Esperion Theraps drug NEXLETOL

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for NEXLETOL
Annual Drug Patent Expirations for NEXLETOL

Nexletol is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

NEXLETOL drug price trends.

This drug has forty-one patent family members in sixteen countries.

The generic ingredient in NEXLETOL is bempedoic acid. One supplier is listed for this compound. Additional details are available on the bempedoic acid profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top